Literature DB >> 24269686

MicroRNA-221 promotes colorectal cancer cell invasion and metastasis by targeting RECK.

Jun Qin1, Meng Luo2.   

Abstract

MicroRNAs (miRNAs) have recently emerged as regulators of metastasis. We provide insight into the behavior of miR-221 in colorectal cancer (CRC) metastasis by showing that miR-221 is significantly upregulated in metastatic CRC cell lines and tissues. miR-221 overexpression enhances, whereas miR-221 depletion reduces CRC cell migration and invasion in vitro and metastasis in vivo. We identify RECK as a direct target of miR-221, reveal its expression to be inversely correlated with miR-221 in CRC samples and show that its re-introduction reverses miR-221-induced CRC invasiveness. Collectively, miR-221 is an oncogenic miRNA which may regulate CRC migration and invasion through targeting RECK.
Copyright © 2013 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Colorectal cancer; Metastasis; RECK; miR-221

Mesh:

Substances:

Year:  2013        PMID: 24269686     DOI: 10.1016/j.febslet.2013.11.014

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  31 in total

1.  miR-15a-5p, A Novel Prognostic Biomarker, Predicting Recurrent Colorectal Adenocarcinoma.

Authors:  Christos K Kontos; Panagiotis Tsiakanikas; Margaritis Avgeris; Iordanis N Papadopoulos; Andreas Scorilas
Journal:  Mol Diagn Ther       Date:  2017-08       Impact factor: 4.074

Review 2.  Regulation of microRNAs in cancer metastasis.

Authors:  Juliette M C Bouyssou; Salomon Manier; Daisy Huynh; Samar Issa; Aldo M Roccaro; Irene M Ghobrial
Journal:  Biochim Biophys Acta       Date:  2014-02-22

3.  Inhibition of miR-221 alleviates LPS-induced acute lung injury via inactivation of SOCS1/NF-κB signaling pathway.

Authors:  Tao Wang; Lihua Jiang; Xiaoyong Wei; Zhenghua Dong; Bo Liu; Junbo Zhao; Lijuan Wang; Peilin Xie; Yuxia Wang; Shangyou Zhou
Journal:  Cell Cycle       Date:  2019-07-11       Impact factor: 4.534

Review 4.  Targeting M3 Muscarinic Receptors for Colon Cancer Therapy.

Authors:  Jessica Felton; Shien Hu; Jean-Pierre Raufman
Journal:  Curr Mol Pharmacol       Date:  2018       Impact factor: 3.339

Review 5.  Mutual regulation of microRNAs and DNA methylation in human cancers.

Authors:  Sumei Wang; Wanyin Wu; Francois X Claret
Journal:  Epigenetics       Date:  2017-01-06       Impact factor: 4.528

6.  Transcriptomic and proteomic analyses reveal key innate immune signatures in the host response to the gastrointestinal pathogen Campylobacter concisus.

Authors:  Nadeem O Kaakoush; Nandan P Deshpande; Si Ming Man; Jose A Burgos-Portugal; Faisal A Khattak; Mark J Raftery; Marc R Wilkins; Hazel M Mitchell
Journal:  Infect Immun       Date:  2014-12-08       Impact factor: 3.441

Review 7.  MicroRNAome genome: a treasure for cancer diagnosis and therapy.

Authors:  Ioana Berindan-Neagoe; Paloma del C Monroig; Barbara Pasculli; George A Calin
Journal:  CA Cancer J Clin       Date:  2014-08-07       Impact factor: 508.702

8.  Prognostic value of miR-221-3p, miR-342-3p and miR-491-5p expression in colon cancer.

Authors:  Kun Tao; Jing Yang; Zhenhua Guo; Yuemei Hu; Haihui Sheng; Hengjun Gao; Hongyu Yu
Journal:  Am J Transl Res       Date:  2014-07-18       Impact factor: 4.060

9.  Overexpression of MicroRNA-221 is associated with poor prognosis in non-small cell lung cancer patients.

Authors:  Yahui Zhang; Yanpeng Zhao; Shengjie Sun; Zhefeng Liu; Yixin Zhang; Shunchang Jiao
Journal:  Tumour Biol       Date:  2016-01-29

10.  MiR-590-5p regulates cell proliferation, apoptosis, migration and invasion in oral squamous cell carcinoma by targeting RECK.

Authors:  Wei-Wei Bao; You-Ling Shi; Yan Ma; Xing-Hui Qu; Guang-Ming Pang; Lei Yang
Journal:  Histol Histopathol       Date:  2021-01-15       Impact factor: 2.303

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.